BAKER G LEONARD JR
Known title: DirectorCIK: 0001201715
BAKER G LEONARD JR's purchase track record
BAKER G LEONARD JR has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/17/2026 | CORT | $3.31M | +149.8% | +230.7% | +13.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CORT | ▲ Buy | Open Market | 75,782 | $2.5M | 3/17/2026 | View on chart |
| CORT | ▲ Buy | Open Market | 24,218 | $813K | 3/17/2026 | View on chart |
| CORT | ▲ Buy | Option Exercise | 30,000 | $455K | 1/27/2026 | View on chart |
| CORT | ▲ Buy | Option Exercise | 30,000 | $176K | 1/27/2026 | View on chart |
| CORT | ▲ Buy | Option Exercise | 30,000 | $364K | 1/27/2026 | View on chart |
| CORT | ▲ Buy | Option Exercise | 25,000 | $352K | 1/27/2026 | View on chart |
| CORT | ▲ Buy | Option Exercise | 25,000 | $263K | 1/27/2026 | View on chart |
| CORT | ▼ Sell | Gift | 0 | $0 | 1/1/2026 | View on chart |
| CORT | ▼ Sell | Gift | 0 | $0 | 1/1/2025 | View on chart |
| CORT | ▼ Sell | Gift | 0 | $0 | 7/17/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CORT Featured in Low-Beta Healthcare Stock List
Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.
CORT Featured in Low-Beta Healthcare Stock List. Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.